Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-106269

Director sold 129,672 shares at $19.52 ($2,530,562)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kersten Dirk · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-11 Sale : show line 1 in the form 10b5-1 −129,672 $19.52 $2,530,562 4,644,386 I
Open-market sales · 129,672 sh · avg $19.52 · $2,530,562
Loading xslF345X05/ownership.xml…